Key Insights

Highlights

Treatment Research

10 treatments under study, led by Ifosfamide

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Phase 2 (1)
Phase 4 (1)

Trial Status

Unknown2

Clinical Trials (2)

Showing 2 of 2 trials
NCT02533700Phase 2Unknown

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

NCT01746992Phase 4Unknown

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Showing all 2 trials

Research Network

Common Treatments

  • Ifosfamide1
  • Vincristine1
  • Etoposide Phosphate1
  • Methotrexate1
  • Cyclophosphamide1

Active Sponsors

  • Shandong Provincial Hospital1
  • Ruijin Hospital1

Top Investigators

Related Conditions

  • Enteropathy Associated T Cell Lymphoma2
  • Angioimmunoblastic T Cell Lymphoma2
  • Alknegative Anaplastic Large Cell Lymphoma2
  • Peripherial T Cell Lymphomanot Otherwise Specified1
  • Hepatosplenic T Cell Lymphoma1

Activity Timeline